Fibrodysplasia ossificans progressiva in a feline, a case report
Abstract
Fibrodysplasia ossificans progressive (FOP) is a rare genetic pathology that causes heterotopic ossification in connective tissues due to mutations in the ACVR1 gene, causing severe movement restrictions and chronic pain. In veterinary medicine, it is low frequency makes it difficult to diagnose and treat in different species. The aim of this study is to describe the diagnostic and therapeutic approach to FOP in felines, based on the analysis of a clinical case in a 7-year-old male cat, presented at the Bet Lasante clinic, in Riobamba, Ecuador, with an atypical growth in the right hind limb as the reason for consultation. The methodology used was quantitative, non-experimental and longitudinal, with multiple clinical evaluations, diagnostic imaging and laboratory tests that allowed confirming the diagnosis. After surgical intervention by excisional biopsy and treatment with glucocorticoids for three months, there was a notable improvement in the patient's quality of life. However, postoperative recurrence limited long-term success, highlighting the need to explore additional therapeutic approaches to control recurrences and improve long-term outcomes.
Downloads
Metrics
References
Anwar, S., & Yokota, T. (2023). Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers. Genes, 14(12), 2162. https://doi.org/10.3390/genes14122162
Casal, M. L., Engiles, J. B., Zakošek Pipan, M., Berkowitz, A., Porat-Mosenco, Y., Mai, W., Wurzburg, K., Xu, M.-Q., Allen, R., ODonnell, P. A., Henthorn, P. S., Thompson, K., & Shore, E. M. (2019). Identification of the Identical Human Mutation in ACVR1 in 2 Cats With Fibrodysplasia Ossificans Progressiva. Veterinary Pathology, 56(4), 614-618. https://doi.org/10.1177/0300985819835585
Castañeda Amigo, P., Rodríguez Díaz, M., Castañeda Gueimonde, C. M., & Amigo Rodríguez, P. A. (2021). Fibrodisplasia Osificante Progresiva: Reporte de Caso. Anatomía Digital, 4(2), 78-87. https://doi.org/10.33262/anatomiadigital.v4i2.1619
Convente, M. R., Towler, O. W., Stanley, A. K., Brewer, N. S., Allen, R. S., Kaplan, F. S., & Shore, E. M. (2018). Fibrodysplasia (Myositis) Ossificans Progressiva. En V. de Rajesh, M. D. Thakker, P. Michael, (eds.). Genetics of Bone Biology and Skeletal Disease (pp. 523-545). Elsevier. https://doi.org/10.1016/B978-0-12-804182-6.00030-7
Cordellat, A. (2020, 30 de marzo). Fibrodisplasia Osificante Progresiva. Diario Médico. https://www.proquest.com/docview/2384107436/citation/6A42082BB48F41D6PQ/1
Elamin, M., Almutasim Ibrahim, A., & Omer, A. (2022). Fibrodysplasia Ossificans Progressiva: A Report of Four Cases. Cureus, 14(3). https://doi.org/10.7759/cureus.23392
Fortin, J., Tian, R., Zarrabi, I., Hill, G., Williams, E., Sanchez-Duffhues, G., Thorikay, M., Ramachandran, P., Siddaway, R., Wong, J. F., Wu, A., Apuzzo, L. N., Haight, J., You-Ten, A., Snow, B. E., Wakeham, A., Goldhamer, D. J., Schramek, D., Bullock, A. N., … Mak, T. W. (2020). Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas. Cancer Cell, 37(3), 308-323. https://doi.org/10.1016/j.ccell.2020.02.002
Hwang, C. D., Pagani, C. A., Nunez, J. H., Cherief, M., Qin, Q., Gomez-Salazar, M., Kadaikal, B., Kang, H., Chowdary, A. R., Patel, N., James, A. W., & Levi, B. (2022). Contemporary perspectives on heterotopic ossification. JCI Insight, 7(14). https://doi.org/10.1172/jci.insight.158996
Jacobsen, K. L., Wiebe, V., Davidson, A. P., Murphy, B. G., & Pool, Jr. R. R. (2023). Use of Enrofloxacin and Hydrotherapy in the Management of Fibrodysplasia Ossificans Progressiva (FOP) in a Savannah Cat. Topics in Companion Animal Medicine, 52. https://doi.org/10.1016/j.tcam.2022.100757
Kaliya-Perumal, A.-K., Carney, T. J., & Ingham, P. W. (2020). Fibrodysplasia ossificans progressiva: Current concepts from bench to bedside. Disease Models & Mechanisms, 13(9). https://doi.org/10.1242/dmm.046441
Kamat, T., & Kilpatrick, S. (2020). Fibrodysplasia ossificans progressiva in a cat. Veterinary Record Case Reports, 8(4). https://doi.org/10.1136/vetreccr-2020-001155
Lorenzo, M. D., Jordán Cases, C., Morte Cabistany, C. M., Peñalva, E., & Milagro Jiménez, M. E. (2021). Fibrodisplasia osificante progresiva: Revisión bibliográfica. RSI–Revista Sanitaria de Investigación.
Mejias Rivera, L., Shore, E. M., & Mourkioti, F. (2024). Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva. Biomedicines, 12(4), 779. https://doi.org/10.3390/biomedicines12040779
Murugesu, S., Jones, B. P., Serhal, P., & Ben-Nagi, J. (2024). Successful preimplantation genetic testing for fibrodysplasia ossificans progressiva: A case report. Journal of Medical Case Reports, 18(1), 227. https://doi.org/10.1186/s13256-024-04504-4
Pignolo, R. J., & Kaplan, F. S. (2020). Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva. Expert Opinion on Orphan Drugs, 8(4), 101-109. https://doi.org/10.1080/21678707.2020.1751122
Ramirez-Gonzalez, A., Castañeda-de-la-Fuente, A., Castro-Cervantes, V., Pineda, C., Sandoval, H., & Hidalgo-Bravo, A. (2022). Fibrodysplasia (myositis) ossificans progressiva (FOP). Clinical Rheumatology, 41(6), 1929-1930. https://doi.org/10.1007/s10067-022-06144-9
Sousa, C. P., Viamonte, B., & Vieira, A. (2020). Fibrodisplasia ossificante progressiva: “Stone man syndrome”. Acta Radiológica Portuguesa, 32(2), 31-34. https://doi.org/10.25748/ARP.19276
Towler, O. W., & Shore, E. M. (2022). BMP signaling and skeletal development in fibrodysplasia ossificans progressiva ( FOP ). Developmental Dynamics, 251(1), 144-157. https://doi.org/10.1002/dvdy.387
Trueba, R. (2021). Resolución del caso. Revista de la Asociación Argentina de Ortopedia y Traumatología, 86(3), 437-441. https://lc.cx/2M9u2G
Yang, Y.-S., Kim, J.-M., Xie, J., Chaugule, S., Lin, C., Ma, H., Hsiao, E., Hong, J., Chun, H., Shore, E. M., Kaplan, F. S., Gao, G., & Shim, J.-H. (2022). Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33956-9
Yang, Y.-S., Lin, C., Ma, H., Xie, J., Kaplan, F. S., Gao, G., & Shim, J.-H. (2023). AAV-Mediated Targeting of the Activin A-ACVR1R206H Signaling in Fibrodysplasia Ossificans Progressiva. Biomolecules, 13(9), 1364. https://doi.org/10.3390/biom13091364
Yu, X., Ton, A. N., Niu, Z., Morales, B. M., Chen, J., Braz, J., Lai, M. H., Barruet, E., Liu, H., Cheung, K., Ali, S., Chan, T., Bigay, K., Ho, J., Nikolli, I., Hansberry, S., Wentworth, K., Kriegstein, A., Basbaum, A., & Hsiao, E. C. (2023). ACVR1-activating mutation causes neuropathic pain and sensory neuron hyperexcitability in humans. Pain, 164(1), 43-58. https://doi.org/10.1097/j.pain.0000000000002656
Zorzi, A. R., Delai, P. R., Rosa, H. L. C., Brito, W. E., Montalli, V. A. M., Napimoga, J. C., Napimoga, M. H., & Nociti, F. H. (2022). Fibrodysplasia ossificans progressiva in Brazil: Challenges and strategies to create assistance and educational networks. Orphanet Journal of Rare Diseases, 17(1), 348. https://doi.org/10.1186/s13023-022-02503-6
Copyright (c) 2024 Jose Andres Bayas Galarza, Andrés Santiago Aguilar Caivinagua
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
